ICD-10-CM Code for Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency D55.0 ICD-10 code D55.0 for Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism.
G6PD deficiency, an X-linked disorder, is the most common enzymatic disorder of red blood cells in humans, affecting more than 400 million people worldwide. The clinical expression of G6PD variants encompasses a spectrum of hemolytic syndromes.
The clinical expression of G6PD variants encompasses a spectrum of hemolytic syndromes. Affected patients are most often asymptomatic, but many patients have episodic anemia, while a few have chronic hemolysis.
Levels of G6PD are higher in the newborn than they are in the adult. When high levels are seen in older patients, it invariably reflects the presence of a young red blood cell population with reticulocytosis. See table. G6PD hemolysis is associated with formation of Heinz bodies in peripheral red blood cells.
G6PD deficiency is an inherited condition. It is when the body doesn't have enough of an enzyme called G6PD (glucose-6-phosphate dehydrogenase). This enzyme helps red blood cells work properly. A lack of this enzyme can cause hemolytic anemia. This is when the red blood cells break down faster than they are made.
G6PD deficiency is an X-linked recessive disorder, with an inheritance pattern similar to that of hemophilia and color blindness: males usually manifest the abnormality and females are carriers. Females may be symptomatic if they are homozygous or if inactivation of their normal X chromosome occurs.
Favism is a hemolytic response to the consumption of fava beans, also known as broad beans. Though all individuals with favism show G6PD deficiency, not all individuals with G6PD deficiency show favism.
Description. Glucose-6-phosphate dehydrogenase deficiency is a genetic disorder that affects red blood cells, which carry oxygen from the lungs to tissues throughout the body. In affected individuals, a defect in an enzyme called glucose-6-phosphate dehydrogenase causes red blood cells to break down prematurely.
"Besides the more minor G6PD deficiency, which chiefly affects red blood cells, a severe or complete enzyme deficiency therefore also constitutes an immunodeficiency in the phagocytes," says Reichenbach, summarizing the results of the study.
As many as 400 different genetic variants of G6PD deficiency have been reported, and for 186 the precise mutation is known. The World Health Organization (WHO) has classified variants on the basis of residual enzyme activity and of disease severity.
The disease is due to the lack of an enzyme in red blood cells, glucose-6-phosphate dehydrogenase. It is thought that over 100 million people, of mainly eastern Mediterranean origin, are susceptible to the disease.
Though they look like lima beans, fava beans are less starchy and have a milder taste. Fava beans are creamy, earthy, nutty, slightly sweet, and slightly bitter. Some people say they have a slight cheesy flavor.
What Causes G6PD Deficiency? G6PD deficiency is inherited. Children who have it are born with it because it was passed down in genes from one or both of the parents. The gene responsible for this condition is on the X chromosome .
G6PD can cause hemolytic anemia. This is when the red blood cells break down faster than they are made. Symptoms of hemolytic anemia include: Pale skin.
G6PD deficiency and COVID-19 vaccines Like routine vaccines, COVID-19 vaccines can be safely administered to people with G6PD deficiency. Clinical trials and real-world evidence have not identified any specific concerns regarding COVID-19 vaccines and people with G6PD deficiency.
G6PD is a genetic disorder that happens when your body doesn't have enough glucose-6-phosphate dehydrogenase (G6PD) enzyme. G6PD helps red blood cells work and protects them from harmful substances. G6PD can cause life-threatening hemolytic anemia that requires blood transfusions.
G6PD deficiency and COVID-19 vaccines Like routine vaccines, COVID-19 vaccines can be safely administered to people with G6PD deficiency. Clinical trials and real-world evidence have not identified any specific concerns regarding COVID-19 vaccines and people with G6PD deficiency.
G6PD deficiency is inherited in an X-linked recessive manner and symptoms are more common in males (particularly African Americans and those from certain parts of Africa, Asia, and the Mediterranean).
G6PD is a genetic disorder that happens when your body doesn't have enough glucose-6-phosphate dehydrogenase (G6PD) enzyme. G6PD helps red blood cells work and protects them from harmful substances. G6PD can cause life-threatening hemolytic anemia that requires blood transfusions.
If you have G6PD (Glucose-6-Phosphate Dehydrogenase Deficiency) or Thalassemia (minor), you can donate blood if you meet the haemoglobin requirement.
Glucose-6-phosphate dehydrogenase deficiency anemia. Clinical Information. Hemolytic anemia due to the ingestion of fava beans or after inhalation of pollen from the vicia fava plant by persons with glucose-6-phosphate dehydrogenase deficient erythrocytes.
D55 Anemia due to enzyme disorders. D55.0 Anemia due to glucose-6-phosphate dehydrogenase [G6PD] deficiency. D55.1 Anemia due to other disorders of glutathione metabolism. D55.2 Anemia due to disorders of glycolytic enzymes.
A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
G6PD hemolysis is associated with formation of Heinz bodies in peripheral red blood cells. It is the older erythrocytes that are most G6PD-deficient in affected individuals. These cells are first eliminated in a hemolytic crisis. The younger cells and reticulocytes contain more G6PD.
Evaluate glucose 6-phosphate dehydrogenase (G6PD) deficiency. G6PD deficiency, an X-linked disorder, is the most common enzymatic disorder of red blood cells in humans, affecting more than 400 million people worldwide. The clinical expression of G6PD variants encompasses a spectrum of hemolytic syndromes. Affected patients are most often asymptomatic, but many patients have episodic anemia, while a few have chronic hemolysis.
Two lavender-top (EDTA) tubes or one green-top (heparin) tube and one lavender-top (ED TA) tube or one yellow-top (ACD) tube and one lavender-top (EDTA) tube.
False normal results after hemolysis may occur. See Additional Information. Levels of G6PD are higher in the newborn than they are in the adult. When high levels are seen in older patients, it invariably reflects the presence of a young red blood cell population with reticulocytosis.
G6PD hemolysis is associated with formation of Heinz bodies in peripheral red blood cells. It is the older erythrocytes that are most G6PD-deficient in affected individuals. These cells are first eliminated in a hemolytic crisis. The younger cells and reticulocytes contain more G6PD.
The clinical expression of G6PD variants encompasses a spectrum of hemolytic syndromes. Affected patients are most often asymptomatic, but many patients have episodic anemia, while a few have chronic hemolysis.
Levels of G6PD are higher in the newborn than they are in the adult. When high levels are seen in older patients, it invariably reflects the presence of a young red blood cell population with reticulocytosis.
CPT codes, descriptions and other data only are copyright 2021 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
This Billing and Coding Article provides billing and coding guidance for molecular pathology services, genomic sequencing procedures and other multianalyte assays, multianalyte assays with algorithmic analyses, and applicable proprietary laboratory analyses codes and Tier 1 and Tier 2 molecular pathology procedures.
It is the provider’s responsibility to select codes carried out to the highest level of specificity and selected from the ICD-10-CM code book appropriate to the year in which the service is rendered for the claim (s) submitted.
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.